Duplications of DNA sequences between loci D20S478 and D20S206 at 20q11.2 and between loci D20S902 and D20S480 at 20q13.2 Mark new: Tumor genes in papillary renal cell carcinoma

Laboratory Investigation

Volumn 79, Issue 3, 1999, Pages 311-316

  Palmedo, Gabriele ^a   Fischer, Joachim ^a   Kovacs, Gyula ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 20; CHROMOSOME 20P; CHROMOSOME 20Q; CHROMOSOME ABERRATION; CLINICAL ARTICLE; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GENE MAPPING; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL;

EID: 0032946543     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM, and Meltzer PS (1997). AIB1, a steroid receptor coativator amplified in breast and ovarian cancer. Science 277:965-968.
2. Barks JH, Thompson FH, Taetle R, Yang JM, Stone JF, Wymer JA, Khavari R, Guan XY, Trent JM, Pinkel D, and Nelson MA (1997). Increased chromosome 20 copy number detected by fluorescence in situ hybridisation (FISH) in malignant melanoma. Genes Chromosomes Cancer 19:278-285.
3. Bench AJ, Aldred MA, Humphray SJ, Champion KM, Gilbert JGR, Asimakopoulos FA, Deloukas P, Gwilliam R, Bentley DR, and Green AR (1998). A detailed physical and transcriptional map of the region of chromosome 20 that is deleted in myeloproliferative disorders and refinement of the common deleted region. Genomics 49:351-362.
4. Brinkmann U, Gallo M, Polymeropoulos MH, and Pastan I (1996). The human CAS (cellular apoptosis susceptibility) gene mapping on chromosome 20q13 is amplified in BT474 breast cancer cells and part of aberrant chromosomes in breast and colon cancer cell lines. Genome Res 6:187-194.
5. Bugert P and Kovacs G (1996). Molecular differential diagnosis of renal cell carcinomas by microsatelite analysis. Am J Pathol 149:2081-2088.
6. Collins C, Rommens JM, Kowbel D, Godfrey T, Tanner M, Hwang S, Polikoff D, Nonet G, Cochran J, Myambo K, Jay KE, Froula F, Cloutier T, Kou WL, Yaswen P, Dairkee S, Giovanola J, Hutchinson GB, Isola J, Kallioniemi OP, Palazzolo M, Martin C, Ericsson C, Pinkel D, Albertson D, Li WB, and Gray JW (1998). Positional cloning of ZNF 217 and NABC1: Genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci USA 95:8703-8708.
7. Courjal F, Cuny M, Rodriguez C, Louason G, Speiser P, Katsaros D, Tanner MM, Zeillinger R, and Theillet C (1996). DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumors. Br J Cancer 74:1984-1989.
8. Deng G, Yu M, Chen L-C, Moore D, Kurisu W, Kallioniemi A, Waldman FM, Collins C, and Smith HS (1996). Amplification of oncogene erbB-2 and chromosome 20q in breast cancer determined by differentially competetive polymerase chain reaction. Breast Cancer Res Treat 40:271-281.
9. El-Rifai W, Harper JC, Cummings OW, Hyytinen ER, Frierson HF, Knuutila S, and Powell SM (1998). Consistent genetic alterations in xenografts of proximal stomach and gastroesophageal junction adenocarcinomas. Cancer Res 58:34-37.
10. Fischer J, Palmedo G, von Knobloch R, Bugert P, Prayer-Galetti T, Pagano F, and Kovacs G (1998). Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumors. Oncogene 17:733-739.
11. Fletcher JA, Kozakewich HP, Pavelka K, Holcombe EG, Shamberger RC, Korf B, and Morton C (1991). Consistent cytogenetic aberrations in hepatoblastoma: A common pathway of genetic alterations in embyonal liver and skeletal muscle malignancies? Genes Chromosomes Cancer 3:37-43.
12. Guan XY, Xu J, Anzick SL, Zhang H, Trent JM, and Meltzer PS (1996). Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer. Cancer Res 56: 3446-3450.
13. Kallioniemi A, Kallionemi OP, Piper J, Chen L, Smith HS, Gray JW, Pinkel D, and Waldman FW (1994). Detection and mapping of amplified DNA sequences in breast canceer by comparative genomic hybidization. Proc Natl Acad Sci USA 91:2156-2160.
14. Kaneko Y, Homma C, Maseki N, Sakurai M, Hatam JI (1991). Correlation of chromosome abnormalities with histologial and clinical features in Wilms' and other childhood tumors. Cancer Res 51:5937-5942.
15. Kovacs G (1993). Molecular cytogenetics of renal cell tumors. Adv Cancer Res 62:89-124.
16. Kovacs G, Akhtar M, Beckwith B, Bugert P, Cooper CS, Delahunt B, Eble JN, Fleminh S, Ljungberg B, Medeiros J, Moch H, Reuter VE, Ritz E, Roos G, Schmidt D, Srigley JR, Störkel S, van den Berg E, and Zbar B (1997). The Heidelberg classification of renal cell tumors. J Pathol 183:131-133.
17. Kovacs G, Füzesi L, Emmanuel A, and Kung HF (1991). Cytogenetics of papillary renal cell tumors. Genes Chromosomes Cancer 3:249-255.
18. Palmedo G, Fischer J, and Kovacs G (1997). Fluorescent microsatellite analysis reveals duplication of specific chromosomal regions in papillary renal cell tumors. Lab Invest 77:633-638.
19. Savelieva E, Belair CD, Newton MA, DeVries S, Gray JW, Waldman F, and Reznikoff CA (1997). 20q gain associates with immortalization: 20q13 amplification orrelates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells. Oncogene 14:551-560.
20. Schmidt L, Duh F-M, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky I, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis JT, Casadevall C, Zamarron A, Bernues M, Richard S, Lips CJM, Walther MM, Tsui L-C, Geil L, Orcutt ML, Stackhouse T, Lipan J, Slife L, Brauch H, Decker J, Niehans G, Hughson MD, Moch H, Storkel S, Lerman MI, Linehan WM, and Zbar B (1997). Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16:68-73.
21. Sen S, Zhou H, and White RA (1997). A putative serine/ threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene 14:2195-2200.
22. Sonoda G, Palazzo J, du Manoir S, Godwin AK, Feder M, Yakushiji M, and Testa JR (1997). Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24 and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer 20:320-328.
23. Tanner MM, Tirkkonen M, Kallioniemi A, Isola J, Kuukasjarvi T, Collins C, Kowbel D, Guan XY, Trent J, Gray JW, Meltzer P, and Kallioniemi OP (1996). Independant amplification and frequent coamplification of three nonsyntenic regions on the long arm of chromosome 20 in breast cancer. Cancer Res 56:3441-3445.
24. Tanner MM, Tirkkonen M, Kallioniemi A, Collins C, Stokke T, Karhu R, Kowbel D, Shadravan F, Hintz M, Kuo W-L, Waldman FM, Isola J, and Gray JW (1994). Inreased copy number at 20q13 in breast cancer: Defining the critical region and exclusion of candidate genes. Cancer Res 54:4257-4260.
25. Thorstensen L, Qvist H, Nesland JM, Giercksky KE, and Lothe R (1996). Allelotype profiles of local recurrences and distant metastases from olorectal-cancer patients. Int J Cancer 69:452-456.
26. Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J, and Kallioniemi OP (1998). Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer 21: 177-184.
27. Voorter C, Joos S, Bringuier PP, Vallinga M, Poddighe P, Schalken J, du Manoir S, Ramaekers F, Lichter P, and Hopman A (1995). Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Am J Pathol 146:1341-1354.
28. Williamson JA, Bosher JM, Skinner A, Sheer D, Williams T, and Hurst HC (1996). Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors. Genomics 35:262-264.